Gene Symbol: TIMD4
Full Name: T Cell Immunoglobulin and Mucin Domain Containing 4
Chromosomal Location: 5q33.3
NCBI Gene ID: 10578
OMIM: 610131
Ensembl ID: ENSG00000134030
UniProt: Q9C0J8
The TIMD4 gene encodes TIM-4 (T-cell immunoglobulin and mucin domain-containing protein 4), a phosphatidylserine receptor that plays a critical role in the recognition and engulfment of apoptotic cells . TIMD4 is primarily expressed on macrophages, dendritic cells, and microglia in the brain .
TIMD4 binds specifically to phosphatidylserine (PS) exposed on the surface of apoptotic cells. This recognition mechanism is essential for:
- Apoptotic Cell Clearance: TIMD4 mediates the engulfment of dying cells, preventing the release of intracellular contents that could trigger inflammatory responses
- Immune Tolerance: Proper clearance of apoptotic cells by TIMD4-expressing phagocytes prevents autoimmunity
- Resolution of Inflammation: TIMD4 contributes to the anti-inflammatory environment during tissue repair
In the central nervous system, TIMD4 is expressed on microglia, the resident immune cells of the brain. Microglial TIMD4 plays important roles in:
- Synaptic Pruning: During development, microglia use TIMD4 to recognize and eliminate excess synapses
- Neuroinflammation: TIMD4-mediated clearance of apoptotic neurons may influence neuroinflammatory processes in neurodegenerative diseases
TIMD4 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:
- Microglial Activation: TIMD4 expression on microglia is altered in Alzheimer's disease brains, affecting the clearance of amyloid-beta plaques and apoptotic neurons
- Neuroinflammation: Dysregulated TIMD4 function may contribute to chronic neuroinflammation, a key feature of AD
- Phagocytic Clearance: Impaired TIMD4-mediated clearance of amyloid-beta may lead to plaque accumulation
In Parkinson's disease, TIMD4 may play roles in:
- Dopaminergic Neuron Survival: TIMD4-mediated clearance of dead dopaminergic neurons in the substantia nigra
- Alpha-Synuclein Clearance: Microglial phagocytosis of alpha-synuclein aggregates may involve TIMD4
- Neuroinflammation: TIMD4 contributes to microglial responses in PD
TIMD4 has been studied in ALS context:
- Motor Neuron Degeneration: TIMD4-mediated clearance of dying motor neurons
- Glial Activation: TIMD4 expression on astrocytes and microglia in ALS models
TIMD4 exhibits tissue-specific expression:
- Brain: Expressed on microglia, particularly in regions with high neuronal density
- Immune System: High expression on macrophages, dendritic cells, and splenic marginal zone macrophages
- Peripheral Tissues: Moderate expression in liver, lung, and intestinal tissues
Expression is modulated by inflammatory cytokines and neuronal activity.
TIMD4 represents a potential therapeutic target for neurodegenerative diseases:
- Modulation of Microglial Phagocytosis: Enhancing TIMD4 function could improve clearance of pathological protein aggregates
- Anti-inflammatory Strategies: TIMD4-based therapies could reduce harmful neuroinflammation
- Drug Development: Small molecules targeting TIMD4-PS interaction are being investigated
- TIMD4 polymorphisms have been associated with autoimmune diseases
- Gene expression studies show altered TIMD4 levels in neurodegenerative disease brains
- TIMD4 is part of a gene network involving immune response and phagocytosis genes
Understanding TIMD4 function has clinical relevance for:
- Biomarker Development: TIMD4 expression levels as a marker of microglial activation
- Therapeutic Targeting: Developing modulators of TIMD4 function
- Disease Monitoring: TIMD4 in cerebrospinal fluid as a potential biomarker